Cancer and SOX proteins: new insight into their role in ovarian cancer progression/inhibition

Warning The system is temporarily closed to updates for reporting purpose.

Ashrafizadeh, Milad and Taeb, Shahram and Hushmandi, Kiavash and Orouei, Sima and Shahinozzaman, Md and Zabolian, Amirhossein and Moghadam, Ebrahim Rahmani and Raei, Mehdi and Zarrabi, Ali and Khan, Haroon and Najafi, Masoud (2020) Cancer and SOX proteins: new insight into their role in ovarian cancer progression/inhibition. Pharmacological Research, 161 . ISSN 1043-6618 (Print) 1096-1186 (Online)

Full text not available from this repository. (Request a copy)

Abstract

Transcription factors are potential targets in disease therapy, particularly in cancer. This is due to the fact that transcription factors regulate a variety of cellular events, and their modulation has opened a new window in cancer therapy. Sex-determining region Y (SRY)-related high-mobility group (HMG) box (SOX) proteins are potential transcription factors that are involved in developmental processes such as embryogenesis. It has been reported that abnormal expression of SOX proteins is associated with development of different cancers, particularly ovarian cancer (OC). In the present review, our aim is to provide a mechanistic review of involvement of SOX members in OC. SOX members may suppress and/or promote aggressiveness and proliferation of OC cells. Clinical studies have also confirmed the potential of transcription factors as diagnostic and prognostic factors in OC. Notably, studies have demonstrated the relationship between SOX members and other molecular pathways such as ST6Ga1-I, PI3K, ERK and so on, leading to more complexity. Furthermore, SOX members can be affected by upstream mediators such as microRNAs, long non-coding RNAs, and so on. It is worth mentioning that the expression of each member of SOX proteins is corelated with different stages of OC. Furthermore, their expression determines the response of OC cells to chemotherapy. These topics are discussed in this review to shed some light on role of SOX transcription factors in OC.
Item Type: Article
Uncontrolled Keywords: Cancer therapy; Chemotherapy; MicroRNA; Ovarian cancer; SOX; Transcription factor
Divisions: Faculty of Engineering and Natural Sciences
Sabancı University Nanotechnology Research and Application Center
Depositing User: Ali Zarrabi
Date Deposited: 03 Aug 2023 15:32
Last Modified: 03 Aug 2023 15:32
URI: https://research.sabanciuniv.edu/id/eprint/46839

Actions (login required)

View Item
View Item